Moderna - PowerPoint PPT Presentation


Moderna Becomes Third Covid Vaccine Approved in the UK - Important Updates

The UK has approved Moderna as the third Covid vaccine, with logistical challenges due to required storage at -75C. AstraZeneca's vaccine is easier to distribute. Moderna offers nearly 95% protection from severe Covid, but all vaccines require a second dose for optimal immunity. Uncertainty remains

0 views • 7 slides


Bivalent Booster Vaccines Information and Updates

Stay informed about the latest updates on bivalent booster vaccines including Pfizer and Moderna for pediatric and adolescent populations. Learn about eligibility criteria, dosage, storage, and handling instructions. Find out more about the vaccination process, recommended spacing between doses, and

0 views • 19 slides



Understanding COVID-19 Vaccines: Safety, Effectiveness, and Immunity

COVID-19 vaccines play a crucial role in preventing illness by helping the body develop immunity to the SARS-CoV-2 virus. Vaccines like Pfizer-BioNTech and Moderna utilize mRNA technology to trigger the immune system to produce antibodies against the virus. These vaccines are safe, effective, and pr

0 views • 15 slides


Understanding COVID-19 Vaccination: Importance, Types, and Effectiveness

COVID-19 vaccination is crucial in reducing the likelihood of infection, severe illness, and spread of the virus. Almost everyone over 6 months should get vaccinated, except those with severe allergies to vaccine components. The Pfizer-BioNTech, Moderna, and Novavax vaccines are safe and effective.

0 views • 14 slides


Alpha Office Hours 6/16/2022 Agenda & Updates

Pfizer and Moderna vaccine updates for different age groups, Novavax administration, clinical updates, and myocarditis/pericarditis updates were discussed in the Alpha Office Hours meeting scheduled for June 16, 2022. The agenda also included Vaccine Finder and July 4th shipping updates. The timelin

0 views • 31 slides


Understanding COVID-19 Vaccine Hesitancy and Education in Healthcare

Discussing factors influencing COVID-19 vaccine acceptance, surveys on hesitancy, perspectives of older adults, and strategies for addressing concerns. Details on Pfizer and Moderna vaccines, efficacy data, side effects, and subgroup analyses are provided.

0 views • 17 slides


COVID-19 Vaccine Updates and Recommendations - January 2023

New updates regarding COVID-19 vaccine administration and recommendations have been released, including the ability for clinics to create and manage vaccine supplies for children as young as six months. The Western States Scientific Review Workgroup supports the use of Moderna and Pfizer-BioNTech bi

0 views • 6 slides


Patent Barriers to Local Health Technology Access in South Africa

Health technologies such as COVID-19 vaccines and diagnostic tests face patent barriers in South Africa, hindering local manufacturing and access. Moderna's mRNA vaccine patents are being challenged for delayed technology transfer, impacting vaccine development and commercialization.

0 views • 15 slides


Latest COVID-19 Update and Vaccination Guidelines by Dr. Thomas Dobbs

In the latest update, Dr. Thomas Dobbs emphasizes the importance of COVID-19 vaccination for individuals above 4 years old, with special attention to those above 11 years old. Updated vaccines like Pfizer, Moderna, and Novavax are recommended, with a reminder for those due for vaccination since Sept

0 views • 12 slides